Price of BBIO with the Market Cap of EXEL

If BridgeBio Pharma, Inc. (BBIO) had the market cap of Exelixis, Inc. (EXEL), one BBIO would cost $87.91, 1.11 times today's price of $79.54. The market cap of Exelixis, Inc. ($17.23B) is 1.11 times that of BridgeBio Pharma, Inc. ($15.59B).

Result

With The Market Cap of

$87.91
(1.11x)

BBIO is 0.90x under EXEL

BBIO.US Market Cap
BBIO.US M. Cap:
$15,592,214,349
EXEL.US Market Cap
EXEL.US M. Cap:
$17,233,439,040
Wonder your profit?
Estimated value:
$0.00
BBIO
BBIO is 0.90x under EXEL
BBIO.US Market Cap
BBIO.US M. Cap:
$15,592,214,349
EXEL.US Market Cap
EXEL.US M. Cap:
$17,233,439,040

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

BridgeBio Pharma, Inc. vs Exelixis, Inc.: key figures

BridgeBio Pharma, Inc. BBIO Exelixis, Inc. EXEL
Rank #1420 #1307
Price $79.54 $69.84
Market cap $15.59B $17.23B
Shares Outstanding 196.03M 246.76M
Change (1 day) +1.11% -1.22%
Change (1 year) +22.26% +64.91%

The other way round: EXEL with the market cap of BBIO

$63.19 (0.9x)

If Exelixis, Inc. (EXEL) had the market cap of BridgeBio Pharma, Inc. (BBIO), one EXEL would cost $63.19, 9.52% less than today's price of $69.84.

Price of EXEL with the Market Cap of BBIO

Price of BBIO with the Market Cap of EXEL: the last 12 months

The price of one BBIO if BridgeBio Pharma, Inc. had the market cap of Exelixis, Inc., at the end of each month. Highest: $89.54 (Oct 2026). Lowest: $58.27 (Jan 2026).

  1. $61.75 Dec 2025
  2. $58.27 Jan 2026
  3. $60.66 Feb 2026
  4. $59.05 Mar 2026
  5. $61.21 Apr 2026
  6. $66.95 May 2026
  7. $72.16 Jun 2026
  8. $68.22 Jul 2026
  9. $70.12 Aug 2026
  10. $74.96 Sep 2026
  11. $89.54 Oct 2026
  12. $88.99 Nov 2026

Questions about BridgeBio Pharma, Inc. and Exelixis, Inc.

What would the price of BridgeBio Pharma, Inc. be with the market cap of Exelixis, Inc.?

If BridgeBio Pharma, Inc. (BBIO) had the market cap of Exelixis, Inc. (EXEL), one BBIO would cost $87.91, 1.11 times today's price of $79.54.

How much bigger is Exelixis, Inc. than BridgeBio Pharma, Inc.?

The market cap of Exelixis, Inc. ($17.23B) is 1.11 times that of BridgeBio Pharma, Inc. ($15.59B). In Dec 2025 it was the other way round: BridgeBio Pharma, Inc. was 1.24 times bigger than Exelixis, Inc..

What would the price of Exelixis, Inc. be with the market cap of BridgeBio Pharma, Inc.?

If Exelixis, Inc. (EXEL) had the market cap of BridgeBio Pharma, Inc. (BBIO), one EXEL would cost $63.19, 9.52% less than today's price of $69.84.

How is this price calculated?

The market cap of Exelixis, Inc. ($17.23B) is divided by the number of BBIO in circulation (196.03M). Market cap is the price multiplied by the number of coins or shares in circulation.